{"id":"https://openalex.org/W2044729114","doi":"https://doi.org/10.1034/j.1600-0773.2003.920504.x","title":"\u03b1\u2010Adrenoceptor\u2010Mediated Modulation of 5\u2010HT2 Receptor Agonist Induced Impulsive Responding in a 5\u2010Choice Serial Reaction Time Task","display_name":"\u03b1\u2010Adrenoceptor\u2010Mediated Modulation of 5\u2010HT2 Receptor Agonist Induced Impulsive Responding in a 5\u2010Choice Serial Reaction Time Task","publication_year":2003,"publication_date":"2003-04-16","ids":{"openalex":"https://openalex.org/W2044729114","doi":"https://doi.org/10.1034/j.1600-0773.2003.920504.x","mag":"2044729114","pmid":"https://pubmed.ncbi.nlm.nih.gov/12753409"},"language":"en","primary_location":{"id":"doi:10.1034/j.1600-0773.2003.920504.x","doi":"https://doi.org/10.1034/j.1600-0773.2003.920504.x","is_oa":false,"landing_page_url":"https://doi.org/10.1034/j.1600-0773.2003.920504.x","pdf_url":null,"source":{"id":"https://openalex.org/S62051601","display_name":"Pharmacology & Toxicology","issn_l":"0901-9928","issn":["0901-9928","1600-0773"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology & Toxicology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013022683","display_name":"Tiina Koskinen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I175532246","display_name":"University of Eastern Finland","ror":"https://ror.org/00cyydd11","country_code":"FI","type":"education","lineage":["https://openalex.org/I175532246"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tiina Koskinen","raw_affiliation_strings":["A I Virtanen Institute, University of Kuopio, Kuopio, Finland","A. I. Virtanen Institute, University of Kuopio, Kuopio, and Orion Corporation, Orion Pharma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A I Virtanen Institute, University of Kuopio, Kuopio, Finland","institution_ids":["https://openalex.org/I175532246"]},{"raw_affiliation_string":"A. I. Virtanen Institute, University of Kuopio, Kuopio, and Orion Corporation, Orion Pharma","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027596381","display_name":"Antti Haapalinna","orcid":"https://orcid.org/0000-0002-1179-6898","observed_orcids":["https://orcid.org/0000-0002-1179-6898"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antti Haapalinna","raw_affiliation_strings":[", Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Turku, Finland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078600555","display_name":"Jouni Sirvi\ufffd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jouni Sirvi","raw_affiliation_strings":[", Turku, Finland","A. I. Virtanen Institute, University of Kuopio, Kuopio, and Orion Corporation, Orion Pharma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Turku, Finland","institution_ids":[]},{"raw_affiliation_string":"A. I. Virtanen Institute, University of Kuopio, Kuopio, and Orion Corporation, Orion Pharma","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078600555"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4009,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.46440554,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"92","issue":"5","first_page":"214","last_page":"225"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10042","display_name":"Neural and Behavioral Psychology Studies","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":0.7590000033378601},{"id":"https://openalex.org/keywords/5-ht2c-receptor","display_name":"5-HT2C receptor","score":0.8500000238418579},{"id":"https://openalex.org/keywords/alpha1-adrenergic-receptors","display_name":"alpha1-adrenoceptors","score":0.6570000052452087},{"id":"https://openalex.org/keywords/alpha2-adrenergic-receptors","display_name":"alpha2-adrenoceptors","score":1.0},{"id":"https://openalex.org/keywords/impulsive-responding","display_name":"impulsive responding","score":0.9179999828338623},{"id":"https://openalex.org/keywords/premature-responding","display_name":"premature responding","score":0.921999990940094},{"id":"https://openalex.org/keywords/five-choice-serial-reaction-time-task","display_name":"5-choice serial reaction time task","score":0.8889999985694885},{"id":"https://openalex.org/keywords/digital-object-identifiers","display_name":"digital object identifiers","score":0.5690000057220459},{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":0.984000027179718},{"id":"https://openalex.org/keywords/atipamezole","display_name":"atipamezole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.3449999988079071},{"id":"https://openalex.org/keywords/response-control","display_name":"response control","score":0.49900001287460327},{"id":"https://openalex.org/keywords/attention","display_name":"attention","score":0.6790000200271606},{"id":"https://openalex.org/keywords/compulsive-behaviour","display_name":"compulsive behaviour","score":0.8479999899864197},{"id":"https://openalex.org/keywords/head-twitches","display_name":"head twitches","score":0.49000000953674316},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5960000157356262},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.9100000262260437}],"concepts":[{"id":"https://openalex.org/C2780648677","wikidata":"https://www.wikidata.org/wiki/Q425296","display_name":"Prazosin","level":4,"score":0.8849848508834839},{"id":"https://openalex.org/C2781114239","wikidata":"https://www.wikidata.org/wiki/Q7454700","display_name":"Serial reaction time","level":3,"score":0.7488704323768616},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7455563545227051},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6458590626716614},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5571298599243164},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.5065566301345825},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4511699378490448},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.434231698513031},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.4291415214538574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42249369621276855},{"id":"https://openalex.org/C200220013","wikidata":"https://www.wikidata.org/wiki/Q753586","display_name":"5-HT2 receptor","level":5,"score":0.421600878238678},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4147113561630249},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4119079113006592},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37530550360679626},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3390687108039856},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2813558578491211},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.277513712644577},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.16613075137138367},{"id":"https://openalex.org/C171606756","wikidata":"https://www.wikidata.org/wiki/Q506132","display_name":"Psychometrics","level":2,"score":0.0},{"id":"https://openalex.org/C40506919","wikidata":"https://www.wikidata.org/wiki/Q7452469","display_name":"Sequence learning","level":2,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004192","descriptor_name":"Discrimination, Psychological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007175","descriptor_name":"Impulsive Behavior","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D007215","descriptor_name":"Indophenol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007215","descriptor_name":"Indophenol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D007215","descriptor_name":"Indophenol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011942","descriptor_name":"Receptors, Adrenergic, alpha","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011942","descriptor_name":"Receptors, Adrenergic, alpha","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012691","descriptor_name":"Serial Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D044402","descriptor_name":"Receptor, Serotonin, 5-HT2A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044405","descriptor_name":"Receptor, Serotonin, 5-HT2C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1034/j.1600-0773.2003.920504.x","doi":"https://doi.org/10.1034/j.1600-0773.2003.920504.x","is_oa":false,"landing_page_url":"https://doi.org/10.1034/j.1600-0773.2003.920504.x","pdf_url":null,"source":{"id":"https://openalex.org/S62051601","display_name":"Pharmacology & Toxicology","issn_l":"0901-9928","issn":["0901-9928","1600-0773"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology & Toxicology","raw_type":"journal-article"},{"id":"pmid:12753409","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12753409","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology & toxicology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":87,"referenced_works":["https://openalex.org/W95063195","https://openalex.org/W1606859536","https://openalex.org/W1809659791","https://openalex.org/W1865252654","https://openalex.org/W1893531325","https://openalex.org/W1895729847","https://openalex.org/W1959120323","https://openalex.org/W1964576983","https://openalex.org/W1965424617","https://openalex.org/W1966975557","https://openalex.org/W1967784102","https://openalex.org/W1970861223","https://openalex.org/W1972745276","https://openalex.org/W1974843265","https://openalex.org/W1977947329","https://openalex.org/W1978443369","https://openalex.org/W1980348146","https://openalex.org/W1982241974","https://openalex.org/W1983874969","https://openalex.org/W1984470666","https://openalex.org/W1986740825","https://openalex.org/W1992968336","https://openalex.org/W1994561821","https://openalex.org/W1996618171","https://openalex.org/W1996657079","https://openalex.org/W2000447219","https://openalex.org/W2003720775","https://openalex.org/W2009164474","https://openalex.org/W2014464860","https://openalex.org/W2016736110","https://openalex.org/W2016783203","https://openalex.org/W2018140837","https://openalex.org/W2020146737","https://openalex.org/W2020635303","https://openalex.org/W2026379800","https://openalex.org/W2030731052","https://openalex.org/W2032844445","https://openalex.org/W2034352356","https://openalex.org/W2038068351","https://openalex.org/W2038361574","https://openalex.org/W2039534965","https://openalex.org/W2041806334","https://openalex.org/W2051922296","https://openalex.org/W2052919428","https://openalex.org/W2054084881","https://openalex.org/W2054194857","https://openalex.org/W2054279548","https://openalex.org/W2057478907","https://openalex.org/W2058458572","https://openalex.org/W2067072320","https://openalex.org/W2070092269","https://openalex.org/W2070290419","https://openalex.org/W2072071169","https://openalex.org/W2072802031","https://openalex.org/W2074756660","https://openalex.org/W2075901584","https://openalex.org/W2076432636","https://openalex.org/W2077505677","https://openalex.org/W2082422831","https://openalex.org/W2087542866","https://openalex.org/W2088276883","https://openalex.org/W2089262925","https://openalex.org/W2089315440","https://openalex.org/W2089318524","https://openalex.org/W2091219420","https://openalex.org/W2094026124","https://openalex.org/W2094065740","https://openalex.org/W2103044052","https://openalex.org/W2112327636","https://openalex.org/W2117719880","https://openalex.org/W2121018669","https://openalex.org/W2124407078","https://openalex.org/W2125725959","https://openalex.org/W2126466713","https://openalex.org/W2139856187","https://openalex.org/W2142961847","https://openalex.org/W2153853866","https://openalex.org/W2158090607","https://openalex.org/W2158109323","https://openalex.org/W2240286220","https://openalex.org/W2259794087","https://openalex.org/W2264160417","https://openalex.org/W2296733908","https://openalex.org/W2299585472","https://openalex.org/W2317070699","https://openalex.org/W2400995186","https://openalex.org/W4301266567"],"related_works":["https://openalex.org/W2034352356","https://openalex.org/W2094026124","https://openalex.org/W1986445373","https://openalex.org/W2003720775","https://openalex.org/W2134552387","https://openalex.org/W2084785603","https://openalex.org/W2065805167","https://openalex.org/W2028356284","https://openalex.org/W1972864533","https://openalex.org/W6990765594"],"abstract_inverted_index":{"The":[0,49,99],"activation":[1,64,273],"of":[2,12,19,29,46,57,65,74,96,104,126,137,163,189,212,216,235,242,252,263,286,294,301,327,335,343],"5-HT2A":[3,66],"receptors":[4,33,67,321],"has":[5,34],"been":[6,35],"shown":[7],"to":[8,37,52,90,132,198,261,330,341],"enhance":[9],"the":[10,24,27,55,72,80,82,97,102,124,134,138,161,171,200,210,233,250,284,292,299,304,318,325,331],"probability":[11,56,162,188,215,234,251,293],"premature":[13,58,164,217,236,295],"responding,":[14,237],"regarded":[15,41],"as":[16,42],"a":[17,111,140,239],"form":[18],"motor":[20,332],"impulsive":[21,275],"behaviour.":[22,48],"At":[23],"behavioural":[25],"level,":[26],"interaction":[28,316],"alpha-adrenoceptors":[30,323],"and":[31,93,114,143,227,277,297,322],"5-HT2":[32,271,305,320],"linked":[36],"head":[38],"twitch":[39],"behaviour,":[40],"an":[43,62,116,129,289,315],"experimental":[44],"model":[45],"compulsive":[47],"aim":[50],"was":[51,88,148,196,258],"determine":[53],"whether":[54],"responding":[59,190,253,276,296],"induced":[60],"by":[61,71,283],"excess":[63],"can":[68,280],"be":[69,281],"modulated":[70],"blockade":[73,285],"alpha1-":[75],"or":[76,120,151,176],"alpha2-":[77],"adrenoceptors.":[78],"In":[79,128],"experiments,":[81],"5-choice":[83],"serial":[84],"reaction":[85],"time":[86],"task":[87],"used":[89],"measure":[91],"attention":[92],"response":[94,328],"control":[95,329],"rats.":[98,127],"experiments":[100],"assessed":[101],"effects":[103,186],"(+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane":[105],"hydrochloride":[106],"(DOI)":[107],"0.1-0.2":[108],"mg/kg":[109,265],"subcutaneously,":[110],"5-HT2A/2C":[112],"agonist,":[113],"prazosin,":[115],"alpha1-adrenoceptor":[117],"antagonist,":[118,146],"alone":[119,150],"in":[121,152,307,324,339],"combination,":[122],"on":[123,181,187,214,246],"performance":[125],"additional":[130],"experiment":[131],"examine":[133],"possible":[135],"role":[136],"alpha2-adrenoceptors,":[139],"potent,":[141],"selective":[142],"specific":[144],"alpha2-adrenoceptor":[145],"atipamezole,":[147],"given":[149,180,220],"combination":[153],"with":[154,303],"DOI.":[155,266],"Results":[156],"showed":[157],"that":[158,262,270,342],"DOI":[159,213,224],"increased":[160,232,249],"responses,":[165],"but":[166,192,255],"it":[167],"did":[168,207],"not":[169,208,259],"affect":[170],"choice":[172],"accuracy.":[173],"Prazosin":[174],"(0.1":[175,204],"0.3":[177],"mg/kg,":[178,205],"subcutaneously),":[179],"its":[182,247],"own":[183,248],"had":[184],"no":[185],"prematurely,":[191,254],"prazosin":[193],"(0.3":[194,244],"mg/kg.)":[195],"able":[197],"attenuate":[199,209],"DOI-induced":[201],"responding.":[202,218],"Atipamezole":[203],"s.c.)":[206],"effect":[211,257,279],"When":[219],"at":[221],"lower":[222],"doses,":[223],"(0.03":[225,229],"mg/kg)":[226,230,245],"atipamezole":[228,243],"synergistically":[231],"whereas":[238],"higher":[240],"dose":[241],"this":[256,278,308],"additive":[260],"0.1":[264],"These":[267,310],"data":[268],"indicate":[269],"receptor":[272],"enhances":[274,291],"diminished":[282],"alpha1-adrenoceptors.":[287],"Atipamezole,":[288],"alpha2-antagonist,":[290],"shares":[298],"mechanism":[300],"action":[302],"agonist":[306],"respect.":[309],"results":[311],"provide":[312],"evidence":[313],"for":[314],"between":[317],"serotonergic":[319],"modulation":[326],"impulsivity":[333],"type":[334],"behaviour":[336,345],"(premature":[337],"responding)":[338],"addition":[340],"compulsory":[344],"(head":[346],"shakes)":[347],"found":[348],"previously.":[349]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}